{"id":58482,"date":"2024-02-27T18:38:32","date_gmt":"2024-02-27T18:38:32","guid":{"rendered":"https:\/\/medsname.com\/lukotas\/"},"modified":"2026-04-30T10:24:12","modified_gmt":"2026-04-30T10:24:12","slug":"lukotas","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/lukotas\/","title":{"rendered":"Lukotas"},"content":{"rendered":"
\n

\u26a1 Quick Answer \u2014 What is Lukotas?<\/h3>\n

Lukotas<\/strong> inneholder montelukast<\/strong>, an oral preventer for asthma and allergic rhinitis. Montelukast blocks cysteinyl leukotriene receptors (CysLT1)<\/strong>, mediators released by mast cells and eosinophils that drive bronchoconstriction, mucus production, and airway oedema. Used as add-on preventer therapy for asthma, especially exercise-induced and allergy-triggered asthma, and for allergic rhinitis. Each tablet contains 4 \/ 5 \/ 10 mg<\/strong>, produsert av Intas Pharmaceuticals<\/strong>. Taken once daily in the evening<\/strong>.<\/p>\n

Important \u2014 neuropsychiatric warning:<\/strong> the FDA added a black-box warning in 2020 noting reports of mood changes, sleep disturbance, anxiety, depression, and (rarely) suicidal ideation with montelukast. Discuss any new mood symptoms with your prescriber.<\/p>\n<\/div>\n

\nHva du f\u00e5r med MedsBase:<\/strong> WHO-GMP-sertifisert produsent \u00b7 Diskret emballasje \u00b7 Verdensomspennende levering \u00b7 1 400+ verifiserte kundeanmeldelser<\/a>\n<\/div>\n

\ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n

Hvorfor bestille fra MedsBase<\/h3>\n

V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n

\n\ud83d\udd12 Kryptert kasse<\/strong> \u00b7 \ud83d\udcb3 Verifisert betalingsbehandler<\/strong> \u00b7 \ud83d\ude9a Verdensomspennende frakt<\/strong> \u00b7 \u2b50 4,9\/5 fra 1 400+ kunder<\/strong>\n<\/div>\n

What Is Lukotas?<\/h2>\n

Lukotas is a montelukast (LTRA) preparation manufactured by Intas Pharmaceuticals at WHO-GMP certified facilities. Internationally montelukast is sold as Singulair (MSD). Available as 4 mg, 5 mg, and 10 mg tablets \u2014 strengths chosen by age and indication.<\/p>\n

How Does Lukotas Work?<\/h2>\n

Cysteinyl leukotrienes (LTC4, LTD4, LTE4) are inflammatory lipid mediators released by mast cells, eosinophils, and basophils when activated by allergen, exercise, cold air, or aspirin. They bind CysLT1 receptors on airway smooth muscle, eosinophils, and bronchial epithelium \u2014 driving bronchoconstriction, eosinophil recruitment, airway oedema, and mucus hypersecretion. Montelukast selectively blocks CysLT1, breaking this cascade.<\/p>\n

Bruk og indikasjoner<\/h2>\n